Alkermes plc (Nasdaq: ALKS) today announced plans to present new research related to ALKS 2680 at SLEEP 2025, the 38th annual meeting of the Associated Professional Sleep Societies (APSS), taking ...

Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat presentation at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 ...

In the assessment of 12-month price targets, analysts unveil insights for Alkermes, presenting an average target of $41.83, a high estimate of $52.00, and a low estimate of $33.00.

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced plans to present new research related to ALKS 2680 at SLEEP 2025, the 38th annual meeting of the ...

On Tuesday, RBC Capital analysts reiterated a Sector Perform rating for Alkermes stock (NASDAQ: ALKS), maintaining a $40.00 price target, which sits between the current analyst range of ...

DUBLIN, May 29, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced plans to present new research related to ALKS 2680 at SLEEP 2025, the 38 th annual meeting of the Associated ...

The Magic unveiled their new logo at a special event inside the Kia Center on Tuesday. (Willie J. Allen Jr./Orlando Sentinel) “This is No. 1 for me because of the history behind it,” said ...

--Alkermes plc today announced plans to present new research related to ALKS 2680 at SLEEP 2025, the 38 th annual meeting of the Associated Professional Sleep Societies, taking place June 8-11 ...

After 16 years with the same jersey and 14 years with the same logo, the Orlando Magic unveiled a massive rebrand by paying homage to their roots.. All the variations of the NEW @OrlandoMagic Logo ...

Basketball fans and sneakerheads are one step closer to the launch of Chicago Sky forward Angel Reese's signature line. On Wednesday, Reebok officially unveiled Reese's signature logo on social media.

--Alkermes plc today announced the presentation of accepted research at key scientific conferences this spring, including presentations largely related to its psychiatry products LYBALVI ® and ...